MAPT and Alzheimer disease: In a recent study, SAD was modelled with human induced pluripotent stem cell (hiPSC)-derived organoids and treated with serum to replicate the blood brain breakdown in AD recapitulating Aβ and p-Tau accumulation and a reduced function of astrocytes (Chen et al. 2021).